Site menu

Search by ticker code:
Generic filters


Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Why the Sigma (ASX:SIG) share price is jumping higher

The Sigma Healthcare Ltd (ASX: SIG) share price is going up after upgrading its profit guidance for FY22.

Sigma is a pharmacy and distribution business. The Amcal pharmacy business is a key profit generator for the company.

Sigma’s profit upgrade

The healthcare business announced that after a late flow of demand for some COVID-related products – rapid antigen tests – it is expecting its underlying EBITDA (EBITDA explained) for the year ending 31 January 2022 to beat previous guidance.

Underlying EBITDA is now expected to be 10% to 15% higher than last year. That compares to the previous guidance in December of around 10% down.

Shift to NPAT

Sigma also said that with much of its investment in infrastructure and transformation close to completion, and to simplify its financial reporting, it is going to shift the focus from underlying EBITDA to reported net profit after tax (NPAT). I think this could be a useful thing for investors to get a better understanding of the value of the Sigma share price.

NPAT guidance

The company is expecting reported NPAT to be a loss of between $5 million to $10 million for the year. It explained this is largely due to the software as a service (SaaS) accounting policy change (of more than $30 million) in the current year.

The improved position due to rapid antigen tests was partially offset by other costs including the implementation of its enterprise resource planning (ERP) solution and related business disruption, as well as the impact of the closure of its Rowville Distribution Centre in late January.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content